Journal
TRENDS IN IMMUNOLOGY
Volume 32, Issue 1, Pages 19-25Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.it.2010.10.002
Keywords
-
Categories
Funding
- NCI NIH HHS [R01 CA100062, R01 CA141438-01A1, P30 CA076292, R01 CA100062-08, R01 CA084488-12, R01 CA141438, R01 CA084488] Funding Source: Medline
- NATIONAL CANCER INSTITUTE [P30CA076292, R01CA141438, R01CA100062, R01CA084488] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Myeloid-derived suppressor cells (MDSCs) are one of the main cell populations responsible for regulating immune responses. MDSCs accumulate during tumor progression, autoimmunity, chronic infection and other pathological conditions, and can potently suppress T cell function. Recent studies have demonstrated the ability of MDSCs to modulate the activity of NK and myeloid cells and have implicated MDSCs in the induction of regulatory T cells. Here, we discuss recent findings that describe the molecular mechanisms that regulate the expansion and function of MDSCs, as well as recent attempts to use MDSCs in cell therapy for different pathologic conditions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available